Efficacy and safety of the hypoxia-activated prodrug TH-302 in combination with gemcitabine and nab-paclitaxel in human tumor xenograft models of pancreatic cancer

Jessica D SunThreshold Pharmaceuticals, South San Francisco, CA, USACorrespondence[email protected]

Qian LiuThreshold Pharmaceuticals, South San Francisco, CA, USA

Dharmendra AhluwaliaThreshold Pharmaceuticals, South San Francisco, CA, USA

Wenwu LiThreshold Pharmaceuticals, South San Francisco, CA, USA

Fanying MengThreshold Pharmaceuticals, South San Francisco, CA, USA

Yan WangThreshold Pharmaceuticals, South San Francisco, CA, USA

Deepthi BhupathiThreshold Pharmaceuticals, South San Francisco, CA, USA

Ayesha S RuprellThreshold Pharmaceuticals, South San Francisco, CA, USA

Charles P HartThreshold Pharmaceuticals, South San Francisco, CA, USA

Your download is now in progress and you may close this window